C. Angelini

Active 1972–2025

Also published as
C Angelini
151
Papers
20,156
Citations
90
h-index
150
i10-index

Citations

Citations per year for C. Angelini1973: 1 citations1974: 2 citations1975: 3 citations1976: 4 citations1977: 4 citations1978: 2 citations1979: 3 citations1980: 7 citations1981: 4 citations1982: 7 citations1983: 11 citations1984: 7 citations1985: 6 citations1986: 2 citations1987: 12 citations1988: 8 citations1989: 9 citations1990: 16 citations1991: 16 citations1992: 22 citations1993: 47 citations1994: 41 citations1995: 53 citations1996: 83 citations1997: 87 citations1998: 72 citations1999: 105 citations2000: 120 citations2001: 84 citations2002: 79 citations2003: 72 citations2004: 90 citations2005: 95 citations2006: 127 citations2007: 114 citations2008: 126 citations2009: 125 citations2010: 156 citations2011: 150 citations2012: 121 citations2013: 130 citations2014: 154 citations2015: 141 citations2016: 158 citations2017: 102 citations2018: 106 citations2019: 469 citations2020: 596 citations2021: 508 citations2022: 339 citations2023: 256 citations2024: 390 citations2025: 128 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,815 citing papers, 25.9% of this breakdownItaly: 767 citing papers, 10.9% of this breakdownUnited Kingdom: 688 citing papers, 9.8% of this breakdownFrance: 383 citing papers, 5.5% of this breakdownGermany: 334 citing papers, 4.8% of this breakdownCanada: 315 citing papers, 4.5% of this breakdownChina: 268 citing papers, 3.8% of this breakdownNetherlands: 249 citing papers, 3.5% of this breakdownJapan: 232 citing papers, 3.3% of this breakdownSpain: 230 citing papers, 3.3% of this breakdownAustralia: 189 citing papers, 2.7% of this breakdownSwitzerland: 105 citing papers, 1.5% of this breakdown
0%25.9%Other 20.5%

Fields

  • Biochemistry, Genetics and Molecular Biology62.4%
  • Medicine27.8%
  • Neuroscience6.9%
  • Agricultural and Biological Sciences0.4%
  • Environmental Science0.4%
  • Nursing0.4%
  • Other1.7%

Topics

  • Muscle Physiology and Disorders12.2%
  • Mitochondrial Function and Pathology8.2%
  • Genetic Neurodegenerative Diseases5.2%
  • Neurogenetic and Muscular Disorders Research4.8%
  • Cardiomyopathy and Myosin Studies4.3%
  • Metabolism and Genetic Disorders3.7%
  • Other61.6%

Coauthors

All papers

Open in search
  1. Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells

    Authors: , , , , - Nature Protocols 2012 cited by 1,006

  2. Regulation of ER-mitochondria contacts by Parkin via Mfn2

    Authors: , , , , , , , , , , , , , , , - Pharmacological Research 2018 cited by 211

  3. 229th ENMC international workshop: Limb girdle muscular dystrophies – Nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neuromuscular Disorders 2018 cited by 384

  4. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 1998 cited by 919

  5. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , - Neurobiology of Disease 2012 cited by 221

  6. Redefining phenotypes associated with mitochondrial DNA single deletion

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maria Lucia Valentino, Liliana Vercelli, Massimo Zeviani, Gabriele Siciliano - Journal of Neurology 2015 cited by 106

  7. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north‐east Italian population sample

    Authors: , , , , , , , - Clinical Genetics 2009 cited by 167

  8. European consensus for starting and stopping enzyme replacement therapy in adult patients with Pompe disease: a 10‐year experience

    Authors: , , , , , , , , , , , , , - European Journal of Neurology 2017 cited by 173

  9. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Muscle & Nerve 2010 cited by 157

  10. A novel clinical tool to classify facioscapulohumeral muscular dystrophy phenotypes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Neurology 2016 cited by 99

  11. Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb–MyoD pathways in muscle regeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Brain 2006 cited by 328

  12. Reliability of the North Star Ambulatory Assessment in a multicentric setting

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claudio Bruno, Marcello Villanova, Giuseppe Vita, Maria Alice Donati, Enrico Bertini, Eugenio Mercuri - Neuromuscular Disorders 2009 cited by 229

  13. SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy

    Authors: , , , , , , , , , , , , , , , , - Neurology 2010 cited by 217

  14. Large scale genotype–phenotype analyses indicate that novel prognostic tools are required for families with facioscapulohumeral muscular dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maura Servida, Gabriele Siciliano, Giuliano Tomelleri, Rossella Tupler - Brain 2013 cited by 126

  15. Circulating microRNAs as biomarkers of muscle differentiation and atrophy in ALS

    Authors: , , , - Clinical Neuropathology 2015 cited by 81

  16. Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - JAMA Network Open 2020 cited by 62

  17. LGMD. Identification, description and classification.

    Authors: - 2020 cited by 55

  18. Gene for chronic proximal spinal muscular atrophies maps to chromosome 5q

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 1990 cited by 399

  19. Improved diagnosis of Becker muscular dystrophy by dystrophin testing

    Authors: , , , , , - Neurology 1989 cited by 292

  20. Interpreting Genetic Variants in Titin in Patients With Muscle Disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan De Bleecker, Maurizio Moggio, Tiziana Mongini, Giacomo P. Comi, Lucio Santoro, Eugenio Mercuri, Elena Pegoraro, Marina Mora, Peter Hackman, Bjarne Udd, Vincenzo Nigro - JAMA Neurology 2018 cited by 93

  21. Autophagy dysregulation in Danon disease

    Authors: , , , - Cell Death and Disease 2017 cited by 78

  22. Advances in Dystrophinopathy Diagnosis and Therapy

    Authors: , , - Biomolecules 2023 cited by 26

  23. Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies.

    Authors: , , , , , , , , - 1991 cited by 401

  24. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: A CoQ10-responsive condition

    Authors: , , , , , , , , , , , , , - Neurology 2005 cited by 192